Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.
The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback